報價延遲最少15分鐘:2025/01/21 08:54 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.99/-1.61
|
|
企業價值
217.66M
|
| 資產負債 |
|
每股賬面淨值
1.62
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
82.00K
|
|
每股收益
0.01
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:54 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. |